ChemicalBook >
?? ???? >(S)-3-(4-(2-(4-fluorophenyl)-5,5-diMethyl-1,3-dioxan-2-yl)butanoyl)-4-phenyloxazolidin-2-one
(S)-3-(4-(2-(4-fluorophenyl)-5,5-diMethyl-1,3-dioxan-2-yl)butanoyl)-4-phenyloxazolidin-2-one
(S)-3-(4-(2-(4-fluorophenyl)-5,5-diMethyl-1,3-dioxan-2-yl)butanoyl)-4-phenyloxazolidin-2-one ??? ???
?? ??:
953805-20-4
???:
(S)-3-(4-(2-(4-fluorophenyl)-5,5-diMethyl-1,3-dioxan-2-yl)butanoyl)-4-phenyloxazolidin-2-one
???(??):
(S)-3-(4-(2-(4-fluorophenyl)-5,5-diMethyl-1,3-dioxan-2-yl)butanoyl)-4-phenyloxazolidin-2-one;3-{4-[2-(4-fluorophenyl)-5,5-dimethyl-[1,3]dioxin-2-yl]butyryl}(4S)-phenyl-1,3-oxazolidin-2-one;2-Oxazolidinone, 3-[4-[2-(4-fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-, (4S)-
CBNumber:
CB62735625
???:
C25H28FNO5
??? ??:
441.49
MOL ??:
953805-20-4.mol
(S)-3-(4-(2-(4-fluorophenyl)-5,5-diMethyl-1,3-dioxan-2-yl)butanoyl)-4-phenyloxazolidin-2-one ??
?? ?
583.3±50.0 °C(Predicted)
??
1?+-.0.06 g/cm3(Predicted)
???
soluble in DCM, Ethyl Acetate
??? ??
??
??? ??
??? ??
?? ?? (pKa)
-3.09±0.40(Predicted)
??
?? ?? ???
??
(S)-3-(4-(2-(4-fluorophenyl)-5,5-diMethyl-1,3-dioxan-2-yl)butanoyl)-4-phenyloxazolidin-2-one C??? ??, ??, ??
??
(4S)-3-[4-[2-(4-Fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-2-oxazolidinone is an intermediate in the synthesis of (3’R,3R,4R)-Ezetimibe (E974990), a structural analog of Ezetimibe (E975000). Ezetimibe is an antihyperlipoproteinemic and a cholesterol absorption inhibitor.
(S)-3-(4-(2-(4-fluorophenyl)-5,5-diMethyl-1,3-dioxan-2-yl)butanoyl)-4-phenyloxazolidin-2-one ?? ?? ? ???
???
?? ??
(S)-3-(4-(2-(4-fluorophenyl)-5,5-diMethyl-1,3-dioxan-2-yl)butanoyl)-4-phenyloxazolidin-2-one ?? ??
???( 7)?? ??
China 5
India 1
United States 1
Global 7
